Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases

Adherence to antiretroviral therapy in pregnancy and during the first year post-partum in HIV-positive women in Ukraine

Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines

Effective exposure to atazanavir during pregnancy, regardless of tenofovir use

A comparison of the pharmacokinetics of raltegravir during pregnancy and postpartum

Low darunavir exposure during pregnancy with 800/100mg darunavir/r QD dosing

Uptake and outcomes of HCV treatment in children and young adults with HIV/HCV co-infection in Europe

Children living with HIV in Ukraine: response to antiretroviral therapy (ART) and duration of first-line regimens

Using CD4 Percentage and Age to Optimize Pediatric Antiretroviral Therapy Initiation

Post-licensing safety of fosamprenavir in HIV-infected children in Europe.

Pharmacokinetics of Pediatric Lopinavir/Ritonavir Tablets in Children When Administered Twice Daily According to FDA weight bands.

HIV-1 resistance after randomized virologic switch at 1,000 or 30,000 c/ml in children.

Moving on up: tracking young people with perinatal HIV as they transition to adult care in Europe

Double dosing of ritonavir in twice-daily darunavir-containing regimens: an example of a lack of appropriate formulations in paediatrics

Increasing abacavir use in HIV-1-infected pregnant women in Europe: effectiveness and safety data